Terms: = Germ cell tumor AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Treatment
262 results:
1. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem cells by Blocking the STAT3 Signaling Pathway.
Yuk N; Jung HJ
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197
[TBL] [Abstract] [Full Text] [Related]
2. CD133 significance in glioblastoma development: in silico and in vitro study.
Abdoli Shadbad M; Nejadi Orang F; Baradaran B
Eur J Med Res; 2024 Mar; 29(1):154. PubMed ID: 38448914
[TBL] [Abstract] [Full Text] [Related]
3. treatment-related Neuroendocrine Prostate Carcinoma-Diagnostic and Molecular Correlates.
Gopalan A
Adv Anat Pathol; 2024 Mar; 31(2):70-79. PubMed ID: 38223983
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic model for assessing the human glioma cell malignancy grade based on MDM2, MELK, sox2, CDK4, DR5 and OCT4 gene expression.
Tyagunova EE; Drozd SF; Kalennik OV; Samoylenkova NS; Savchenko EA; Danilov GV; Pavlova GV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):43-51. PubMed ID: 38054226
[TBL] [Abstract] [Full Text] [Related]
5. Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma cells: Involvement of HDACs and EGFR.
Laschuk Herlinger A; Lovatto Michaelsen G; Sinigaglia M; Fratini L; Nogueira Debom G; Braganhol E; Brunetto de Farias C; Lunardi Brunetto A; Tesainer Brunetto A; da Cunha Jaeger M; Roesler R
Neuromolecular Med; 2023 Dec; 25(4):573-585. PubMed ID: 37740824
[TBL] [Abstract] [Full Text] [Related]
6. CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity.
Bhutada I; Khambati F; Cheng SY; Tiek DM; Duckett D; Lawrence H; Vogelbaum MA; Mo Q; Chellappan SP; Padmanabhan J
Neuro Oncol; 2024 Jan; 26(1):70-84. PubMed ID: 37551745
[TBL] [Abstract] [Full Text] [Related]
7. Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXRα neurogenic pathway.
Liu RZ; Choi WS; Jain S; Xu X; Elsherbiny ME; Glubrecht DD; Tessier AG; Easaw JC; Fallone BG; Godbout R
Neuro Oncol; 2023 Dec; 25(12):2177-2190. PubMed ID: 37499046
[TBL] [Abstract] [Full Text] [Related]
8. Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.
Martell E; Kuzmychova H; Senthil H; Kaul E; Chokshi CR; Venugopal C; Anderson CM; Singh SK; Sharif T
Acta Neuropathol Commun; 2023 Jul; 11(1):110. PubMed ID: 37420311
[TBL] [Abstract] [Full Text] [Related]
9. CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners.
Söhngen C; Thomas DJ; Skowron MA; Bremmer F; Eckstein M; Stefanski A; Driessen MD; Wakileh GA; Stühler K; Altevogt P; Theodorescu D; Klapdor R; Schambach A; Nettersheim D
FEBS J; 2023 Oct; 290(20):4864-4876. PubMed ID: 37254618
[TBL] [Abstract] [Full Text] [Related]
10. Chi3l1 Is a Modulator of Glioma Stem cell States and a Therapeutic Target in Glioblastoma.
Guetta-Terrier C; Karambizi D; Akosman B; Zepecki JP; Chen JS; Kamle S; Fajardo JE; Fiser A; Singh R; Toms SA; Lee CG; Elias JA; Tapinos N
Cancer Res; 2023 Jun; 83(12):1984-1999. PubMed ID: 37101376
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing sox2 expression.
Jiang X; Zhang Y; Yuan Y; Jin Z; Zhai H; Liu B; Li Y; Zhang C; Chen M; Shi Y; Yan D; Pu J; Chen Y; Yang C
Int J Biol Sci; 2023; 19(6):1681-1697. PubMed ID: 37063420
[TBL] [Abstract] [Full Text] [Related]
12. sox2 downregulation of PML increases HCMV gene expression and growth of glioma cells.
Wen L; Wang XZ; Qiu Y; Zhou YP; Zhang QY; Cheng S; Sun JY; Jiang XJ; Rayner S; Britt WJ; Chen J; Hu F; Li FC; Luo MH; Cheng H
PLoS Pathog; 2023 Apr; 19(4):e1011316. PubMed ID: 37058447
[TBL] [Abstract] [Full Text] [Related]
13. B7H6 silencing increases chemosensitivity to dacarbazine and suppresses cell survival and migration in cutaneous melanoma.
Mohammadi A; Najafi S; Amini M; Baradaran B; Firouzamandi M
Melanoma Res; 2023 Jun; 33(3):173-183. PubMed ID: 37053079
[TBL] [Abstract] [Full Text] [Related]
14. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
Martínez-Bosch N; Vilariño N; Alameda F; Mojal S; Arumí-Uria M; Carrato C; Aldecoa I; Ribalta T; Vidal N; Bellosillo B; Menéndez S; Del Barco S; Gallego O; Pineda E; López-Martos R; Hernández A; Mesia C; Esteve-Codina A; de la Iglesia N; Balañá C; Martínez-García M; Navarro P
Cells; 2023 Mar; 12(6):. PubMed ID: 36980184
[TBL] [Abstract] [Full Text] [Related]
15. METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of sox2.
Wang Y; Yang Z
Brain Behav; 2023 May; 13(5):e2936. PubMed ID: 36977205
[TBL] [Abstract] [Full Text] [Related]
16. VAV3 regulates glioblastoma cell proliferation, migration, invasion and cancer stem‑like cell self‑renewal.
Miao R; Huang D; Zhao K; Li Y; Zhang X; Cheng Y; Guo N
Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36960857
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of PIM Kinases Promotes Neuroblastoma cell Differentiation to a Neuronal Phenotype.
Julson JR; Quinn CH; Bownes LV; Hutchins SC; Stewart JE; Aye J; Yoon KJ; Beierle EA
J Pediatr Surg; 2023 Jun; 58(6):1155-1163. PubMed ID: 36907773
[TBL] [Abstract] [Full Text] [Related]
18. Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients.
Baliña-Sánchez C; Aguilera Y; Adán N; Sierra-Párraga JM; Olmedo-Moreno L; Panadero-Morón C; Cabello-Laureano R; Márquez-Vega C; Martín-Montalvo A; Capilla-González V
Front Immunol; 2023; 14():1022676. PubMed ID: 36776860
[TBL] [Abstract] [Full Text] [Related]
19. WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.
Mitchell K; Sprowls SA; Arora S; Shakya S; Silver DJ; Goins CM; Wallace L; Roversi G; Schafer RE; Kay K; Miller TE; Lauko A; Bassett J; Kashyap A; D'Amato Kass J; Mulkearns-Hubert EE; Johnson S; Alvarado J; Rich JN; Holland EC; Paddison PJ; Patel AP; Stauffer SR; Hubert CG; Lathia JD
Genes Dev; 2023 Feb; 37(3-4):86-102. PubMed ID: 36732025
[TBL] [Abstract] [Full Text] [Related]
20. Targeting the epigenome of cancer stem cells in pediatric nervous system tumors.
Freire NH; Jaeger MDC; de Farias CB; Nör C; Souza BK; Gregianin L; Brunetto AT; Roesler R
Mol Cell Biochem; 2023 Oct; 478(10):2241-2255. PubMed ID: 36637615
[TBL] [Abstract] [Full Text] [Related]
[Next]
